EC Number |
Activating Compound |
Reference |
---|
3.4.16.5 | 1-chloro-3-tosylamido-2-heptanone |
10% increase of activity at 10 mM |
679935 |
3.4.16.5 | antipain |
15 increase of activity at 0.1 mM |
679935 |
3.4.16.5 | leupeptin |
20% increase of activity at 0.1 mM |
679935 |
3.4.16.5 | EDTA |
25% increase of activity at 10 mM |
679935 |
3.4.16.5 | o-phenanthroline |
4% increase of activity at 5 mM |
679935 |
3.4.16.5 | pepstatin A |
5% increase of activity at 0.1 mM |
679935 |
3.4.16.5 | N-ethylmaleimide |
8% increase of activity at 10 mM |
679935 |
3.4.16.5 | Karp2 |
a single co-expression of Kar2p leads to a 28% enhancement in extracellular CPY activity, relative to the control strain |
731493 |
3.4.16.5 | proteinase A |
active proteinase A is essential to the activity of carboxypeptidase Y |
683009 |
3.4.16.5 | Kar2p, Pdi1p, Ero1p |
co-expression of Kar2p, Pdi1p and Ero1p give a synergistic effect on CPY expression, of which activity is 1.7times higher than that of the control strain |
731493 |